JP2020511114A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020511114A5 JP2020511114A5 JP2019530815A JP2019530815A JP2020511114A5 JP 2020511114 A5 JP2020511114 A5 JP 2020511114A5 JP 2019530815 A JP2019530815 A JP 2019530815A JP 2019530815 A JP2019530815 A JP 2019530815A JP 2020511114 A5 JP2020511114 A5 JP 2020511114A5
- Authority
- JP
- Japan
- Prior art keywords
- adenovirus
- acid sequence
- amino acid
- seq
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1620968.6 | 2016-12-09 | ||
| GBGB1620968.6A GB201620968D0 (en) | 2016-12-09 | 2016-12-09 | Adenovirus polynucleotides and polypeptides |
| PCT/IB2017/057738 WO2018104911A1 (en) | 2016-12-09 | 2017-12-07 | Adenovirus polynucleotides and polypeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020511114A JP2020511114A (ja) | 2020-04-16 |
| JP2020511114A5 true JP2020511114A5 (https=) | 2021-01-21 |
Family
ID=58222021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019530815A Pending JP2020511114A (ja) | 2016-12-09 | 2017-12-07 | アデノウイルスポリヌクレオチド及びポリペプチド |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US11414679B2 (https=) |
| EP (1) | EP3551224A1 (https=) |
| JP (1) | JP2020511114A (https=) |
| KR (1) | KR20190092471A (https=) |
| CN (1) | CN110300597A (https=) |
| AR (1) | AR110502A1 (https=) |
| AU (1) | AU2017371944B2 (https=) |
| BE (1) | BE1025029B1 (https=) |
| BR (1) | BR112019010906A2 (https=) |
| CA (1) | CA3045973A1 (https=) |
| EA (1) | EA201991116A1 (https=) |
| GB (1) | GB201620968D0 (https=) |
| IL (1) | IL266942A (https=) |
| MX (1) | MX2019006725A (https=) |
| WO (1) | WO2018104911A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014236207B2 (en) | 2013-03-14 | 2019-05-23 | Salk Institute For Biological Studies | Oncolytic adenovirus compositions |
| KR20250081944A (ko) | 2014-09-24 | 2025-06-05 | 솔크 인스티튜트 포 바이올로지칼 스터디즈 | 종양 살상 바이러스 및 이의 사용방법 |
| EP4155411A1 (en) | 2016-02-23 | 2023-03-29 | Salk Institute for Biological Studies | Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics |
| WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| GB201620968D0 (en) * | 2016-12-09 | 2017-01-25 | Glaxosmithkline Biologicals Sa | Adenovirus polynucleotides and polypeptides |
| EP3532082A4 (en) | 2016-12-12 | 2020-08-26 | Salk Institute for Biological Studies | SYNTHETIC ADENOVIRUS TUMOR TARGETING AND THEIR USES |
| MX2019013259A (es) | 2017-05-08 | 2020-01-13 | Gritstone Oncology Inc | Vectores de neoantigeno de alfavirus. |
| WO2019016680A1 (en) * | 2017-07-17 | 2019-01-24 | Glaxosmithkline Biologicals Sa | ANTIGEN CONSTRUCTS OF LYSSAVIRUS |
| AU2018351308B2 (en) * | 2017-10-16 | 2021-12-02 | Glaxosmithkline Biologicals Sa | Replication competent adenoviral vectors |
| MX2020010499A (es) | 2018-04-09 | 2020-10-28 | Salk Inst For Biological Studi | Composiciones de adenovirus oncoliticas con propiedades aumentadas de replicacion. |
| JP2021526831A (ja) * | 2018-06-12 | 2021-10-11 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | アデノウイルスポリヌクレオチド及びポリペプチド |
| US20210283238A1 (en) | 2018-08-07 | 2021-09-16 | Glaxosmithkline Biologicals Sa | Novel processes and vaccines |
| EP3897846A1 (en) | 2018-12-21 | 2021-10-27 | GlaxoSmithKline Biologicals SA | Methods of inducing an immune response |
| MX2021014525A (es) | 2019-05-30 | 2022-03-17 | Gritstone Bio Inc | Adenovirus modificados. |
| CA3174985A1 (en) * | 2020-04-07 | 2021-10-14 | Lung Biotechnology Pbc | Adenoviral expression vector and methods and cell lines for production |
| KR20230046313A (ko) | 2020-08-06 | 2023-04-05 | 그릿스톤 바이오, 인코포레이티드 | 다중에피토프 백신 카세트 |
| CA3259723A1 (en) * | 2022-06-22 | 2023-12-28 | AskBio Inc. | ADENOVIRUS-BASED NUCLEIC ACIDS AND ASSOCIATED PROCESSES |
| IL326497A (en) * | 2023-08-11 | 2026-04-01 | Joint Stock Company «Biocad» | Adapted sequence of the adenovirus E2A gene for the creation of vectors based on ADENO-ASSOCIATED VIRUSES derivatives |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4436727A (en) | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| CA1331443C (en) | 1987-05-29 | 1994-08-16 | Charlotte A. Kensil | Saponin adjuvant |
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| US5240846A (en) | 1989-08-22 | 1993-08-31 | The Regents Of The University Of Michigan | Gene therapy vector for cystic fibrosis |
| EP0468520A3 (en) | 1990-07-27 | 1992-07-01 | Mitsui Toatsu Chemicals, Inc. | Immunostimulatory remedies containing palindromic dna sequences |
| JP3723231B2 (ja) | 1991-12-23 | 2005-12-07 | ディミナコ アクチェンゲゼルシャフト | アジュバント |
| DK0671948T3 (da) | 1992-06-25 | 1997-09-01 | Smithkline Beecham Biolog | Vaccinepræparat indeholdende adjuvanser |
| ATE157882T1 (de) | 1993-03-23 | 1997-09-15 | Smithkline Beecham Biolog | 3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen |
| PT729473E (pt) | 1993-11-17 | 2001-02-28 | Deutsche Om Arzneimittel Gmbh | Dissacaridos de glucosamina metodo para a sua preparacao composicao farmaceutica contendo os mesmos e sua utilizacao |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| ATE509102T1 (de) | 1994-07-15 | 2011-05-15 | Univ Iowa Res Found | Immunomodulatorische oligonukleotide |
| AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
| GB9620795D0 (en) | 1996-10-05 | 1996-11-20 | Smithkline Beecham Plc | Vaccines |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| WO1998010087A1 (en) | 1996-09-06 | 1998-03-12 | Trustees Of The University Of Pennsylvania | Chimpanzee adenovirus vectors |
| AU722624B2 (en) | 1996-09-06 | 2000-08-10 | Trustees Of The University Of Pennsylvania, The | An inducible method for production of recombinant adeno-associated viruses utilizing T7 polymerase |
| ES2241042T3 (es) | 1996-10-11 | 2005-10-16 | The Regents Of The University Of California | Conjugados de polinucleotido inmunoestimulador/ molecula inmunomoduladora. |
| US6303347B1 (en) | 1997-05-08 | 2001-10-16 | Corixa Corporation | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| US6113918A (en) | 1997-05-08 | 2000-09-05 | Ribi Immunochem Research, Inc. | Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors |
| US6764840B2 (en) | 1997-05-08 | 2004-07-20 | Corixa Corporation | Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| GB9711990D0 (en) | 1997-06-11 | 1997-08-06 | Smithkline Beecham Biolog | Vaccine |
| US6645495B1 (en) | 1997-08-29 | 2003-11-11 | Antigenics, Inc. | Compositions of saponin adjuvants and excipients |
| ES2298316T3 (es) | 1997-09-05 | 2008-05-16 | Glaxosmithkline Biologicals S.A. | Emulsiones de aceite en agua que contienen saponinas. |
| GB9718901D0 (en) | 1997-09-05 | 1997-11-12 | Smithkline Beecham Biolog | Vaccine |
| AU5677399A (en) | 1998-08-20 | 2000-03-14 | Wistar Institute Of Anatomy And Biology, The | Methods of augmenting mucosal immunity through systemic priming and mucosal boosting |
| DE69935606T9 (de) | 1998-10-16 | 2021-03-11 | Glaxosmithkline Biologicals S.A. | Adjuvanzsysteme und impfstoffe |
| US7291498B2 (en) | 2003-06-20 | 2007-11-06 | The Trustees Of The University Of Pennsylvania | Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
| ATE449105T1 (de) * | 2004-01-23 | 2009-12-15 | Angeletti P Ist Richerche Bio | Impfstoffträger für schimpansen-adenovirus |
| WO2006133911A2 (en) | 2005-06-17 | 2006-12-21 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Hepatitis c virus nucleic acid vaccine |
| EP1957528B1 (en) | 2005-11-30 | 2012-11-07 | University of Copenhagen | A nucleotide vaccine |
| JP2010522540A (ja) | 2007-03-21 | 2010-07-08 | アイディー バイオメディカル コーポレイション オブ ケベック | キメラ抗原 |
| EP2463362B1 (en) * | 2007-11-28 | 2017-11-08 | The Trustees Of The University Of Pennsylvania | Simian subfamily c adenovirus SAdv-31 and uses thereof |
| HUE045093T2 (hu) | 2008-11-21 | 2019-12-30 | Kobenhavns Univ University Of Copenhagen | Immunválasz kiváltása |
| EP2391638B1 (en) | 2009-02-02 | 2018-06-27 | GlaxoSmithKline Biologicals SA | Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |
| WO2012089231A1 (en) | 2010-12-30 | 2012-07-05 | Okairòs Ag | Paramyxovirus vaccines |
| US8865881B2 (en) | 2011-02-22 | 2014-10-21 | California Institute Of Technology | Delivery of proteins using adeno-associated virus (AAV) vectors |
| CN107921118B (zh) | 2015-06-12 | 2022-11-08 | 葛兰素史密丝克莱恩生物有限公司 | 腺病毒多核苷酸和多肽 |
| GB201620968D0 (en) * | 2016-12-09 | 2017-01-25 | Glaxosmithkline Biologicals Sa | Adenovirus polynucleotides and polypeptides |
-
2016
- 2016-12-09 GB GBGB1620968.6A patent/GB201620968D0/en not_active Ceased
-
2017
- 2017-12-07 US US16/466,683 patent/US11414679B2/en active Active
- 2017-12-07 BR BR112019010906A patent/BR112019010906A2/pt not_active IP Right Cessation
- 2017-12-07 AU AU2017371944A patent/AU2017371944B2/en not_active Ceased
- 2017-12-07 EA EA201991116A patent/EA201991116A1/ru unknown
- 2017-12-07 EP EP17838152.1A patent/EP3551224A1/en active Pending
- 2017-12-07 AR ARP170103442A patent/AR110502A1/es unknown
- 2017-12-07 BE BE2017/5910A patent/BE1025029B1/fr not_active IP Right Cessation
- 2017-12-07 WO PCT/IB2017/057738 patent/WO2018104911A1/en not_active Ceased
- 2017-12-07 CN CN201780074539.3A patent/CN110300597A/zh active Pending
- 2017-12-07 JP JP2019530815A patent/JP2020511114A/ja active Pending
- 2017-12-07 CA CA3045973A patent/CA3045973A1/en active Pending
- 2017-12-07 KR KR1020197018883A patent/KR20190092471A/ko not_active Ceased
- 2017-12-07 MX MX2019006725A patent/MX2019006725A/es unknown
-
2019
- 2019-05-28 IL IL266942A patent/IL266942A/en unknown
-
2022
- 2022-05-11 US US17/742,221 patent/US11795478B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020511114A5 (https=) | ||
| JP2018524977A5 (https=) | ||
| JP7274222B2 (ja) | 非ヒト大型類人猿アデノウイルスの核酸配列及びアミノ酸配列、それを含有するベクター、並びにその使用 | |
| JP2020511940A5 (https=) | ||
| AU737780B2 (en) | Methods and reagents for vaccination which generate a CD8 T cell immune response | |
| JP6873054B2 (ja) | アデノウイルスポリヌクレオチド及びポリペプチド | |
| JP7630466B2 (ja) | 抗原がインバリアント鎖（ｃｄ７４）の小断片と連結された融合ペプチド | |
| JP7274223B2 (ja) | マイクロサテライト不安定性（ｍｓｉ）癌の予防及び治療のための共通腫瘍ネオアンチゲンをベースとした万能ワクチン | |
| JP2018523980A5 (https=) | ||
| JP2012516679A5 (https=) | ||
| JP2021526831A (ja) | アデノウイルスポリヌクレオチド及びポリペプチド | |
| CN118308379A (zh) | 爱泼斯坦-巴尔病毒抗原构建体 | |
| TWI901715B (zh) | 大猩猩腺病毒核酸及胺基酸序列，包含彼之載體，及其用途 | |
| HK40031047B (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| HK40031047A (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof | |
| AU775973B2 (en) | Methods and reagents for vaccination which generate a CD8 T cell immune response | |
| AU2004203141B2 (en) | Methods and reagents for vaccination which generate CD8 T cell immune response | |
| NZ759892B2 (en) | Non human great apes adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof |